We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ELEKTA

Elekta develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well a... read more Featured Products: More products

Download Mobile App




MR-Linac System for Difficult Cases Unveiled

By HospiMedica International staff writers
Posted on 16 May 2017
An innovative new MR/RT system that could change cancer care especially for cases that are difficult to treat has been unveiled.

The manufacturer expects the system to go on sale in Europe and globally, later in 2017, when it is expected to receive the CE Mark (Conformité Européenne).

The Elekta Unity was developed by Elekta and is the only Magnetic Resonance Radiation Therapy (MR/RT) system that combines a premium diagnostic quality (1.5T) MRI scanner with an advanced linear accelerator (linac). More...
The system is designed to deliver a precise radiation dose, and at the same time capture high-quality MR images. This will enable clinicians to visualize tumors, and adapt treatment. Unity features a compact, 70 cm wide-bore MRI, a table with a low load height for patient comfort and a soft tabletop, and non-glare room lighting.

Unity is the fruit of a global partnership consortium set up by Elekta with Royal Philips as MR technology partner. The consortium has also developed new clinical and workflow protocols for the system.

Conceptual architect and inventor of the system, Professor Jan Lagendijk, PhD, Head Radiation Oncology, University Medical Center Utrecht, said, “We started the development of an integrated MR-linac system 18 years ago; the presentation of the clinical system is a huge milestone. This system will enable tumor dose escalation and extreme normal tissue sparing, it will also enable shorter and more effective treatment regimens, while its ability to perform functional imaging has the potential to perform better dose painting and tumor response assessment.”


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.